Prosecution Insights
Last updated: October 02, 2026

Brown University

Technology area: Biotechnology & Pharmaceuticals

25 pending office actions • 20 art units • 25 examiners • 0 of 25 (0%) have an AI response strategy ready • 20 patents granted in the last 365 days

Analysis

Brown University manages a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The university currently has 25 pending office actions. These actions are distributed across 20 distinct art units, highlighting the range of scientific research occurring at the institution. This count of 20 distinct art units indicates that the university's patentable output covers many different specialized fields within biotechnology and pharmaceuticals.

The prosecution involves 25 distinct examiners. John R Schnurr is the busiest examiner for the portfolio, with 1 pending office action. The fact that there are 25 distinct examiners for 25 pending office actions across 20 different art units demonstrates a decentralized prosecution landscape for the university's intellectual property. Because each of the 25 pending office actions is being handled by a different examiner, there is no single examiner or small group of examiners that dominates the university's current USPTO activity.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

25
Total Pending OAs
13
Non-Final OAs
11
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (2)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

11
Hard (44%)
9
Medium (36%)
5
Easy (20%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other7 (28%)
§103 only7 (28%)
§112 only4 (16%)
Double-patenting only1 (4%)
Double-patenting + other2 (8%)
Multi-statute (no §101)4 (16%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
48% of docket
2
Information Tech
8% of docket
3
Communications
12% of docket
2
Semiconductors
8% of docket
3
Mechanical / Eng
12% of docket
3
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

250 h
Manual time on pending OAs
50 h
Time saved (low, 20%)
88 h
Time saved (mid, 35%)
2.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SCHNURR, JOHN R 1 72.1% +10.8%
MCANANY, JOHN D 1 67.2% +43.7%
FORRISTALL, JOSHUA L 1 63.9% +17.1%
SAPKOTA, SURAJ 1 0.0% +0.0%
MONTGOMERY, MELISSA JO 1 15.4% +40.0%
NELESKI, ELIZABETH ROSE 1 74.8% +15.7%
NASHER, AHMED ABDULLALIM-M 1 79.1% +32.5%
WRIGHT, ERIC BRANDON 1 — —
KEUP, AIDAN JAMES 1 80.3% +16.4%
OSENBAUGH-STEWART, ELIZA W 1 73.0% +16.7%

Hard Cases (12)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18185281 FRAMEWORK FOR SIMULATING GENERAL MULTI-SCALE PROBLEMS BARRETT, RYAN S 105d overdue
18711899 COMPUTATIONS TRAINED MACHINE LEARNING MODELS FOR NON-DESTRUCTIVE EVALUATION OF MATERIAL AND STRUCTURAL FLAWS FORRISTALL, JOSHUA L —
18436385 PROTEIN SEQUENCE DESIGN METHODS AND USES THEREOF TO PREVENT PROTEIN AGGREGATION SAPKOTA, SURAJ —
18578379 MENTAL IMAGE-BASED NEUROFEEDBACK TO IMPROVE COGNITIVE FUNCTION MONTGOMERY, MELISSA JO —
18391580 SYSTEMS AND METHODS FOR OPERATING ROBOTS USING OBJECT-ORIENTED PARTIALLY OBSERVABLE MARKOV DECISION PROCESSES NELESKI, ELIZABETH ROSE —
18513051 CELL AND COLLAGEN COMPOSITIONS FOR ENGINEERED CARDIAC TISSUE WRIGHT, ERIC BRANDON —
18500768 GENERALIZED THREE DIMENSIONAL MULTI-OBJECT SEARCH KEUP, AIDAN JAMES —
18451325 LANTHANIDE DOUBLE PEROVSKITE NANOCRYSTALS GROOMS, NOA WILLIAM FRAN —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18287052 SYSTEMS AND METHODS FOR SINGLE-ION MASS SPECTROMETRY WITH TEMPORAL INFORMATION OSENBAUGH-STEWART, ELIZA W 42d overdue
18539590 OBJECT-CENTRIC VIDEO REPRESENTATION FOR ACTION PREDICTION NASHER, AHMED ABDULLALIM-M 14d
19172430 DEEP SURFACE LIQUID CRYSTAL DISPLAY SCHNURR, JOHN R —
18784840 PROANGIOGENIC PROTEIN COCKTAILS DELIVERED IN CUSTOM BIOMATERIALS TO REVASCULARIZE ISCHEMIC TISSUE MCANANY, JOHN D —
18711899 COMPUTATIONS TRAINED MACHINE LEARNING MODELS FOR NON-DESTRUCTIVE EVALUATION OF MATERIAL AND STRUCTURAL FLAWS FORRISTALL, JOSHUA L —
18578379 MENTAL IMAGE-BASED NEUROFEEDBACK TO IMPROVE COGNITIVE FUNCTION MONTGOMERY, MELISSA JO —
18391580 SYSTEMS AND METHODS FOR OPERATING ROBOTS USING OBJECT-ORIENTED PARTIALLY OBSERVABLE MARKOV DECISION PROCESSES NELESKI, ELIZABETH ROSE —
18500768 GENERALIZED THREE DIMENSIONAL MULTI-OBJECT SEARCH KEUP, AIDAN JAMES —

Top Art Units

Art UnitApps
2881 2
1675 2
2425 1
3791 1
3658 1
2675 1
1632 1
2666 1
2656 1
1634 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19172430 DEEP SURFACE LIQUID CRYSTAL DISPLAY SCHNURR, JOHN R 2425 §103 Final Rejection — Pending Apr 07, 2025
18784840 PROANGIOGENIC PROTEIN COCKTAILS DELIVERED IN CUSTOM BIOMATERIALS TO REVASCULARIZE ISCHEMIC TISSUE MCANANY, JOHN D — §102§103§112DP Non-Final OA — Pending Jul 25, 2024
18711899 COMPUTATIONS TRAINED MACHINE LEARNING MODELS FOR NON-DESTRUCTIVE EVALUATION OF MATERIAL AND STRUCTURAL FLAWS FORRISTALL, JOSHUA L — §101§102§103§112 Non-Final OA — Pending May 21, 2024
18436385 PROTEIN SEQUENCE DESIGN METHODS AND USES THEREOF TO PREVENT PROTEIN AGGREGATION SAPKOTA, SURAJ — §112 Non-Final OA — Pending Feb 08, 2024
18578379 MENTAL IMAGE-BASED NEUROFEEDBACK TO IMPROVE COGNITIVE FUNCTION MONTGOMERY, MELISSA JO 3791 §101§102§103§112 Non-Final OA — Pending Jan 11, 2024
18391580 SYSTEMS AND METHODS FOR OPERATING ROBOTS USING OBJECT-ORIENTED PARTIALLY OBSERVABLE MARKOV DECISION PROCESSES NELESKI, ELIZABETH ROSE 3658 §101§102§103§112 Non-Final OA — Pending Dec 20, 2023
18539590 OBJECT-CENTRIC VIDEO REPRESENTATION FOR ACTION PREDICTION NASHER, AHMED ABDULLALIM-M 2675 §103 Final Rejection 14d Pending Dec 14, 2023
18513051 CELL AND COLLAGEN COMPOSITIONS FOR ENGINEERED CARDIAC TISSUE WRIGHT, ERIC BRANDON 1632 §101§102§112 Non-Final OA — Pending Nov 17, 2023
18500768 GENERALIZED THREE DIMENSIONAL MULTI-OBJECT SEARCH KEUP, AIDAN JAMES 2666 §101§102§103 Final Rejection — Pending Nov 02, 2023
18287052 SYSTEMS AND METHODS FOR SINGLE-ION MASS SPECTROMETRY WITH TEMPORAL INFORMATION OSENBAUGH-STEWART, ELIZA W 2881 §103 Final Rejection 42d overdue Pending Oct 16, 2023
18282679 PREDICTING VELOCIMETRY USING MACHINE LEARNING MODELS TSAI, TSUNG YIN 2656 §103 Final Rejection 23d Pending Sep 18, 2023
18282463 CHARACTERIZING THE BINDING INTERACTIONS BETWEEN MUSK AND BMP RECEPTORS NICOL, ALEXANDER W 1634 §103DP Final Rejection 87d overdue Pending Sep 15, 2023
18451325 LANTHANIDE DOUBLE PEROVSKITE NANOCRYSTALS GROOMS, NOA WILLIAM FRAN 1759 §102§103 Non-Final OA — Pending Aug 17, 2023
18230872 TESTING COLON CANCER DRUGS FOR IMMUNOMODULATORY EFFECTS GROSS, CHRISTOPHER M 1684 §101§102§103§112 Non-Final OA — Pending Aug 07, 2023
18275897 DEEP OPERATOR NETWORK ANDERSON, SCOTT C 3694 §101§102§112 Non-Final OA — Pending Aug 04, 2023
18260440 POLY-ARGININE DERIVATIVES FOR ENHANCING BRAIN-DERIVED GROWTH FACTOR TO MITIGATE NEUROLOGICAL DISORDERS LEE, JIA-HAI 1658 §112 Final Rejection — Pending Jul 05, 2023
18339980 DECELLULARIZED MAMMALIAN EXTRACELLULAR MATRIX MORSELS, METHODS MAKING AND METHODS OF USING SAME LANDAU, SHARMILA GOLLAMUDI 1653 §103§112 Non-Final OA — Pending Jun 22, 2023
18251868 INHIBITION OF GLYCOGEN SYNTHASE KINASE-3 (GSK-3) HASTINGS, ALISON AZAR 1627 §103Other Final Rejection 62d Pending May 04, 2023
18309548 METHODS AND COMPOSITIONS FOR TREATING, PREVENTING OR REVERSING OBESITY AND OBESITY-RELATED DISORDERS BY OPSIN 3 REGULATION OF HYPOTHALAMIC MELANOCORTIN RECEPTORS ANGELL, JON E 1637 DP Non-Final OA — Pending Apr 28, 2023
18185281 FRAMEWORK FOR SIMULATING GENERAL MULTI-SCALE PROBLEMS BARRETT, RYAN S 2148 §102§103Other Final Rejection 105d overdue Pending Mar 16, 2023
17917672 NANOTIP ION SOURCES AND METHODS GOURLIE, LAURA ELOISE 2881 §103 Final Rejection — Pending Oct 07, 2022
17778375 BISPECIFIC ANTIBODIES AGAINST CHI3L1 AND CTLA4 WITH ENHANCED CYTOTOXIC EFFECTS ON TUMOR CELLS BERHANE, SELAM 1675 §112 Non-Final OA — Pending May 19, 2022
17721618 ELECTRICAL DISSOCIATION OF TISSUE SAMPLES INTO SINGLE CELLS AND/OR SMALLER GROUPS OF CELLS SHI, TINGCHEN 1796 §103§112 Non-Final OA — Pending Apr 15, 2022
17769165 MUSCLE REGENERATION AND GROWTH CHERNYSHEV, OLGA N 1675 §112 Final Rejection 51d overdue Pending Apr 14, 2022
17265751 ORAL FORMULATIONS WITH INCREASED UPTAKE MITCHELL, EDWIN COLEMAN 1619 §103 Non-Final OA — Pending Feb 03, 2021

Managing Brown University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month